PathAI Inc is a provider of AI-powered technology for the pathology laboratory services. The company specializes in delivering the transformative tools for pathologists that can help accelerate drug development in therapeutic areas such as oncology; breast cancer, lung cancer, non-alcoholic steatohepatitis (NASH), and inflammatory bowel diseases, and among others. Its biopharma service offerings include translational research, clinical development, diagnostic development and commercialization, real-world data services, clinical and commercial lab services. The company uses AISight precision-pathology platform, AI-powered algorithms, artificial intelligence, and machine learning technologies in drug development. PathAI is headquartered in Boston, Massachusetts, the US.
Headquarters
United States of America
Address
Suite 10000, 1325 Boylston Street, Boston, Massachusetts, 02215
Website
www.pathai.com
Telephone
1 617 5008457
Industry
Pharmaceuticals and Healthcare
Products and Services
| Services |
|---|
| Translational Research Services |
| Clinical Development |
| Diagnostic Development and Commercialization |
| XYZ |
| XYZ |
| XYZ |
Competitor Comparison
| Key Parameters | PathAI Inc | Paige.AI Inc | Proscia Inc | Systems Oncology LLC |
|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America |
| City | Boston | New York City | Philadelphia | Scottsdale |
| State/Province | Massachusetts | New York | Pennsylvania | Arizona |
| No. of Employees | - | - | 11 | - |
| Entity Type | Private | Private | Private | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Andy Beck | Co-Founder; Chief Executive Officer | Senior Management | - | - |
| Brandon Eldredge | Chief Financial Officer | Senior Management | - | - |
| Tiffany Freitas | Chief Operating Officer | Senior Management | - | - |
| Liz Storti | Chief People Officer | Senior Management | - | - |
| Elizabeth Storti | Chief People Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer